seri
nine
substitut
phenylamino
benzamid
assess
prospect
bactericid
agent
three
clinic
isol
methicillinresist
staphylococcu
aureu
mrsa
aureu
atcc
refer
qualiti
control
strain
minimum
bactericid
concentr
determin
subcultur
aliquot
mic
determin
onto
substancefre
agar
plate
bactericid
kinet
compound
amino
establish
timekil
assay
final
concentr
compound
equal
mic
aliquot
remov
h
time
point
potent
bactericid
agent
compound
exhibit
remark
rapid
concentrationdepend
bactericid
effect
even
mic
h
reduct
bacteri
count
rang
log
cfuml
mic
h
log
cfuml
reduct
bacteri
count
incub
mrsa
reliabl
bactericid
effect
strain
maintain
mic
h
antibiot
resist
invas
pathogen
becom
one
challeng
persist
health
problem
methicillinresist
staphylococcu
aureu
mrsa
becom
common
clinic
relev
multiresist
pathogen
caus
healthcareassoci
communityacquir
bloodstream
infect
mortal
rate
preval
mrsa
increas
worldwid
accord
latest
inform
european
centr
diseas
prevent
control
consid
alarm
european
countri
especi
portug
romania
aureu
isol
invas
infect
identifi
mrsa
although
eg
romania
preval
mrsa
follow
itali
greec
poland
isol
mrsa
comparison
poland
mrsa
isol
constitut
aureu
isol
treatment
failur
vancomycin
therapeut
antimrsa
agent
choic
due
strain
elev
vancomycin
minimum
inhibitori
concentr
mic
valu
ie
lowest
concentr
antimicrobi
inhibit
visibl
growth
microorgan
within
suscept
rang
describ
previous
thu
emerg
mrsa
vancomycinresist
aureu
recent
year
well
make
discoveri
new
molecular
scaffold
prioriti
current
situat
even
necessit
reengin
reposit
old
drug
famili
achiev
adequ
control
bacteria
howev
treatment
aureu
bloodstream
infect
bactericid
antimicrobi
agent
consid
superior
bacteriostat
drug
fact
consid
develop
effect
safe
treatment
option
mrsa
infect
histori
clinic
usag
salicylanilid
date
back
therapi
tinea
capiti
follow
discoveri
anthelmint
properti
mid
nowaday
salicylanilid
sal
class
aromat
compound
possess
wide
rang
interest
pharmacolog
activ
anthelmint
antibacteri
antimycobacteri
antifung
antivir
among
other
despit
studi
sinc
mechan
action
respons
biolog
activ
compound
explain
far
sal
found
inhibit
twocompon
regulatori
system
tc
bacteria
latest
studi
specifi
also
select
inhibitor
product
play
specif
role
initi
expans
control
cellular
respons
tuberculosi
furthermor
salicylanilid
recognis
inhibitor
bacteri
enzym
sortas
aureu
dalaninedalanin
ligas
transglycosylas
aureu
tuberculosi
enzym
particip
secret
variou
protein
biosynthesi
bacteri
cell
wall
recent
salicylanilideslik
deriv
describ
inhibit
two
enzym
essenti
mycobacteria
methionin
aminopeptidas
catalyz
key
step
posttransl
modif
nascent
protein
ii
isocitr
lyas
essenti
metabol
fatti
acid
thu
sal
seem
promis
candid
develop
new
antibacteri
agent
novel
mechan
action
new
agent
could
solut
resist
challeng
studi
followup
paper
recent
publish
articl
synthesi
seri
novel
deriv
salicylamid
phenylamino
benzamid
call
diamid
due
skeleton
gener
structur
see
tabl
describ
previous
antimycobacteri
antibacteri
activ
variou
bacteri
speci
report
compound
express
signific
antibacteri
activ
low
mic
valu
clinic
isol
mrsa
repres
multidrugresist
bacteria
decid
extend
knowledg
antibacteri
properti
compound
mrsa
aim
current
studi
assess
overal
vitro
bactericid
activ
nine
newli
synthes
diamid
depend
time
concentr
clinic
isol
mrsa
repres
multidrugresist
bacteria
best
knowledg
first
studi
deal
evalu
novel
microbiolog
characterist
sal
analogu
reveal
bactericid
effect
synthet
pathway
seri
novel
diamid
describ
recent
structur
see
tabl
confirm
ir
nmr
ms
spectrometri
puriti
compound
check
chn
analysi
mrsa
sa
nation
institut
public
health
pragu
czech
republ
human
origin
suspect
coloni
confirm
pcr
bp
fragment
specif
aureu
detect
isol
test
presenc
meca
gene
encod
methicillin
resist
three
clinic
isol
classifi
vancomycinsuscept
higher
mic
vancomycin
equal
gml
within
suscept
rang
mrsa
methicillinresist
aureu
vsmrsa
mic
vancomycin
see
tabl
vancomycinsuscept
methicillinsuscept
staphylococcu
aureu
vsmssa
atcc
obtain
american
type
cultur
collect
use
refer
qualiti
control
strain
bacteria
store
c
kept
blood
agar
plate
columbia
agar
base
ovin
blood
experi
mbc
mbc
ie
lowest
concentr
antibacteri
agent
requir
kill
particular
bacterium
determin
subcultur
aliquot
l
well
visibl
bacteri
growth
control
well
mic
determin
onto
substancefre
muellerhinton
agar
mha
plate
plate
incub
aerob
c
h
coloni
count
mbc
defin
lowest
concentr
substanc
produc
kill
tabl
chemic
structur
vitro
mic
mbc
gml
valu
test
phenylamino
benzamid
bactericid
effect
individu
compound
particular
strain
mark
bold
h
incub
compar
coloni
count
start
inoculum
ensur
reproduc
mbc
assay
perform
least
triplic
separ
occas
n
h
h
n
oh
r
r
r
comp
r
r
r
mic
gml
mbc
gml
ch
ch
ch
benzyl
r
ch
indolyl
ch
ch
ch
ch
ch
ch
ch
ch
benzyl
amp
cpx
van
timekil
assay
perform
broth
macrodilut
method
accord
previous
describ
methodolog
modif
briefli
flask
contain
steril
fresh
muellerhinton
broth
mhb
appropri
antimicrobi
agent
inocul
test
organ
logarithm
growth
phase
obtain
start
inoculum
concentr
approxim
cfuml
actual
inoculum
concentr
rang
cfuml
final
concentr
antibiot
equal
mic
ml
volum
determin
viabl
count
aliquot
remov
h
time
point
inocul
serial
dilut
steril
phosphat
buffer
salin
aliquot
l
plate
mha
plate
duplic
coloni
count
perform
plate
yield
coloni
mean
calcul
antimicrobi
carryov
control
dilut
visual
inspect
distribut
coloni
plate
observ
possibl
inhibit
growth
site
initi
streak
plate
incub
c
h
number
coloni
determin
ensur
reproduc
timekil
experi
carri
duplic
separ
occas
result
present
mean
experi
growth
control
without
addit
antimicrobi
agent
control
contain
dmso
without
antimicrobi
agent
exclud
antibacteri
activ
solvent
includ
timekil
curv
construct
plot
log
cfu
per
millilitr
versu
time
h
chang
bacteri
concentr
determin
result
analys
evalu
number
strain
yield
log
cfuml
valu
correspond
kill
kill
kill
h
compar
count
h
bactericid
activ
defin
reduct
least
log
total
count
cfuml
origin
inoculum
diamid
seem
promis
candid
antibacteri
agent
strong
antimrsa
activ
publish
recent
present
studi
seri
nine
newli
synthes
diamid
evalu
prospect
bactericid
agent
repres
multidrugresist
bacteria
three
clinic
isol
mrsa
staphylococcu
aureu
atcc
methicillinsuscept
refer
qualiti
control
strain
sinc
sal
analogu
known
compound
bacteriostat
effect
first
studi
sallik
compound
consid
prospect
bactericid
agent
depend
bactericid
effect
compound
time
concentr
evalu
thu
absolut
novel
microbiolog
characterist
compound
reveal
present
studi
recent
mic
valu
diamid
express
molar
concentr
moll
publish
allow
comparison
mbc
valu
present
studi
mic
gml
calcul
record
tabl
along
activ
refer
antibacteri
drug
ampicillin
ciprofloxacin
vancomycin
potenti
bactericid
activ
diamid
assess
use
mbc
assay
mbc
valu
test
compound
record
tabl
well
base
obtain
result
compound
assess
activ
accord
mic
valu
previou
studi
show
low
moder
mbc
valu
four
strain
mbc
valu
compound
exceed
highest
test
drug
concentr
rang
gml
case
compar
mbc
valu
clinic
isol
mrsa
aureu
refer
strain
bactericid
activ
defin
ratio
mbc
mic
tabl
bactericid
activ
express
bold
mention
sal
known
exhibit
bacteriostat
effect
interest
discov
diamid
possess
bactericid
activ
amid
bond
conh
caus
interact
varieti
enzym
therefor
presenc
two
amid
bond
could
respons
bactericid
effect
diamid
mrsa
activ
sal
analogu
result
multipl
mechan
still
investig
exampl
found
sal
capabl
inhibit
transglycosylas
later
stage
aureu
includ
mrsa
cell
wall
biosynthesi
enzym
catalys
step
prior
transpeptid
peptidoglycan
biosynthesi
respons
polymer
lipid
ii
occur
outer
face
membran
sinc
antibacteri
agent
target
cell
wall
biosynthesi
act
bactericid
agent
failur
cell
wall
biosynthesi
due
inhibit
transglycosylas
could
respons
bactericid
activ
diamid
mrsa
base
find
antibacteri
activ
diamid
bactericid
effect
four
test
strain
prospect
bactericid
agent
chosen
subsequ
timekil
curv
studi
determin
real
depend
bactericid
effect
concentr
time
test
timekil
studi
mic
mrsa
isol
aureu
refer
strain
antibacteri
effect
dmso
use
solvent
test
compound
exclud
assay
timekil
curv
solvent
ident
similar
growth
control
extent
bacteri
kill
estim
number
strain
show
decreas
rang
log
cfuml
viabl
cell
count
differ
time
incub
summari
data
present
tabl
base
data
conclud
bactericid
potenc
test
diamid
four
strain
decreas
follow
bactericid
activ
ie
log
cfuml
decreas
observ
mic
strain
time
incub
test
mic
four
strain
compound
g
kill
strain
respect
h
incub
strain
respect
h
incub
find
timekil
studi
four
staphylococci
strain
exposur
compound
summar
tabl
bactericid
activ
ie
log
cfuml
decreas
express
bold
compound
rapid
concentrationdepend
antibacteri
effect
record
clinic
isol
mrsa
time
predict
factor
influenc
antibacteri
activ
log
differ
cfuml
start
inoculum
mic
highest
effici
reduct
bacteri
count
log
cfuml
similar
mic
moder
regrowth
h
caus
loss
bactericid
activ
h
bactericid
effect
maintain
even
mic
h
incub
strain
reduct
log
cfuml
remain
strain
clinic
isol
mrsa
sa
mrsa
sa
aureu
atcc
reliabl
bactericid
effect
record
mic
h
incub
strain
reduct
bacteri
count
log
cfuml
respect
compound
bactericid
effect
mrsa
notic
mic
h
incub
mic
h
incub
reduct
bacteri
count
rang
log
cfuml
effect
kill
achiev
h
concentr
case
compound
regrowth
observ
h
incub
remain
isol
mrsa
sa
sa
bactericid
effect
occur
mic
h
incub
reduct
bacteri
count
log
cfuml
respect
highest
bactericid
effect
record
mrsa
sa
mic
h
incub
reduct
consist
bacteriostat
effect
log
cfuml
observ
concentr
time
isol
bactericid
effect
observ
aureu
refer
strain
compound
demonstr
pattern
bacteriostat
activ
strain
reduct
bacteri
count
rang
log
cfuml
mic
time
case
slight
increas
bacteri
count
ie
overgrowth
compar
start
inoculum
observ
valu
rang
log
cfuml
refer
strain
compound
bactericid
effect
mrsa
maintain
mic
h
incub
reduct
bacteri
count
log
cfuml
respect
potent
bactericid
effect
maintain
h
incub
regrowth
h
incub
caus
loss
bactericid
activ
record
similarli
previou
compound
reason
regrowth
test
organ
h
experi
unknown
probabl
select
resist
mutant
respons
phenomenon
degrad
drug
growth
medium
assum
regrowth
number
strain
show
follow
log
cfuml
decreas
design
incub
time
observ
test
strain
mrsa
sa
concentrationdepend
kill
record
mic
h
incub
log
differ
cfuml
start
inoculum
similar
time
rang
log
cfuml
mrsa
sa
reliabl
bactericid
effect
maintain
mic
h
incub
reduct
bacteri
count
log
cfuml
compound
bacteriostat
activ
aureu
refer
strain
observ
reduct
bacteri
count
rang
log
cfuml
mic
overgrowth
valu
rang
log
cfuml
record
mic
strain
note
staphylococci
strain
similar
mic
mbc
compound
respons
antibacteri
activ
compound
vari
clinic
strain
mrsa
effect
kill
refer
strain
remain
unaffect
mic
discrep
bactericid
result
mbc
assay
compar
timekil
kinet
differ
could
caus
compar
microtit
mbc
assay
macrobroth
timekil
assay
dilut
moreov
although
timekil
assay
labour
intens
time
consum
mbc
assay
recognis
provid
greater
degre
characteris
cell
erad
potenti
antibacteri
agent
concern
antibacteri
effect
gener
import
antibacteri
agent
also
bactericid
higher
concentr
inhibit
bacteri
prolifer
usual
achiev
therapeut
effect
patient
immun
system
capabl
cope
infect
howev
bactericid
therapi
could
produc
better
treatment
result
rapid
reduct
bacteri
load
moreov
case
immun
system
disord
eg
immunosuppress
therapi
aid
patient
etc
bactericid
agent
unequivoc
indic
consid
steadili
escal
number
immunocompromis
patient
endocard
mening
osteomyel
recent
year
necessari
achiev
bacteri
kill
broaden
spectrum
antimicrobi
agent
bactericid
activ
compound
clinic
outcom
mrsa
bacteraemia
significantli
influenc
vancomycin
mic
treatment
failur
exceed
aureu
vancomycin
mic
gml
result
chang
suscept
breakpoint
gml
gml
clinic
laboratori
standard
institut
clsi
well
us
food
drug
administr
fda
recommend
infect
caus
mrsa
strain
elev
vancomycin
mic
gml
altern
therapi
consid
note
base
timekil
assay
present
studi
test
diamid
particularli
compound
exhibit
rapid
bactericid
concentrationdepend
effect
even
mic
effect
isol
mrsa
strain
elev
vancomycin
mic
gml
activ
remain
isol
vancomycin
mic
gml
lower
consid
emerg
decreas
vancomycin
suscept
mrsa
isol
thu
therapeut
efficaci
vancomycin
therapi
aim
determin
potenti
bactericid
role
novel
antibacteri
compound
mrsa
vitro
base
obtain
result
diamid
suitabl
candid
novel
bactericid
activ
compound
present
promis
start
point
investig
ascertain
real
vivo
activ
exact
mechan
action
present
studi
first
evid
bactericid
effect
sal
analogu
strain
reliabl
bactericid
effect
maintain
mic
h
incub
consid
necess
broaden
spectrum
bactericid
agent
diamid
current
studi
novel
mechan
action
could
present
promis
interest
solut
challeng
futur
